Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2007-10-16
2007-10-16
Andres, Janet L. (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S134100, C424S141100, C424S142100, C514S012200
Reexamination Certificate
active
10671034
ABSTRACT:
Methods are provided for treating or inhibiting the formation of tissue fibrosis using IL-13 antagonists, including without limitation soluble forms of the IL-13 receptor.
REFERENCES:
patent: 0 812 913 (1997-12-01), None
patent: WO96/04388 (1996-02-01), None
patent: WO97/31946 (1997-09-01), None
patent: WO97/33913 (1997-09-01), None
patent: WO97/47741 (1997-12-01), None
patent: WO97/47742 (1997-12-01), None
patent: WO98/10638 (1998-03-01), None
E. Choy, Cytokine, vol. 28, pp. 158-161, 2004.
Borrebaeck et al. Current Opinion in Pharmacology, vol. 1, pp. 404-408, 2001.
Feldmann et al, 1998. Springer Seminars in Immunopathology, vol. 20, pp. 211-228.
Aman et al.J. Biol. Chem., 271(46):29265-29270 (1996).
Cheever et al.J. Immunol., 153:753-759 (1994).
Chiaramonte et al.J. Clin. Invest., 104(6):777-785 (1999).
Orchansky et al.J. Biol. Chem., 274(30):20818-20825 (1999).
Zhu et al.J. Clin. Invest., 103(6):779-788 (1999).
Cheever, A.W., “Differential Regulation of Granuloma Size and Hepatic Fibrosis in Schistosome Infections”,Mem. Inst. Oswaldo Cruz,Rio de Janeiro, 92(5):689-692 (1997).
Chiaramonte et al., “IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced bySchistosoma mansonieggs”,J. Immunol.,162:920-930 (1999), Jan.
Chiaramonte Monica G.
Collins Mary
Donaldson Debra
Fitz Lori
Neben Tamlyn
Andres Janet L.
Elrifi, Esq. Ivor R.
Hamud Fozia
Johnson, Esq. David E.
The United States of America as represented by the Department of
LandOfFree
Treatment of fibrosis by antagonism of IL-13 and IL-13... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of fibrosis by antagonism of IL-13 and IL-13..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of fibrosis by antagonism of IL-13 and IL-13... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3901203